Emerging clinical and therapeutic applications of Nigella sativa in gastroenterology
- PMID: 19418593
- PMCID: PMC2678591
- DOI: 10.3748/wjg.15.2170
Emerging clinical and therapeutic applications of Nigella sativa in gastroenterology
Abstract
Nigella sativa (N. sativa) decreases DNA damage and thereby prevents initiation of carcinogenesis in colonic tissue secondary to exposure to toxic agents such as azoxymethane. N. sativa is of immense therapeutic benefit in diabetic individuals and those with glucose intolerance as it accentuates glucose-induced secretion of insulin besides having a negative impact on glucose absorption from the intestinal mucosa. N. sativa administration protects hepatic tissue from deleterious effects of toxic metals such as lead, and attenuates hepatic lipid peroxidation following exposure to chemicals such as carbon tetrachloride.
Comment on
-
Nigella sativa relieves the deleterious effects of ischemia reperfusion injury on liver.World J Gastroenterol. 2008 Sep 7;14(33):5204-9. doi: 10.3748/wjg.14.5204. World J Gastroenterol. 2008. PMID: 18777598 Free PMC article.
References
-
- Al-Johar D, Shinwari N, Arif J, Al-Sanea N, Jabbar AA, El-Sayed R, Mashhour A, Billedo G, El-Doush I, Al-Saleh I. Role of Nigella sativa and a number of its antioxidant constituents towards azoxymethane-induced genotoxic effects and colon cancer in rats. Phytother Res. 2008;22:1311–1323. - PubMed
-
- Norwood AA, Tucci M, Benghuzzi H. A comparison of 5-fluorouracil and natural chemotherapeutic agents, EGCG and thymoquinone, delivered by sustained drug delivery on colon cancer cells. Biomed Sci Instrum. 2007;43:272–277. - PubMed
-
- Ait Mbarek L, Ait Mouse H, Elabbadi N, Bensalah M, Gamouh A, Aboufatima R, Benharref A, Chait A, Kamal M, Dalal A, et al. Anti-tumor properties of blackseed (Nigella sativa L.) extracts. Braz J Med Biol Res. 2007;40:839–847. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
